🟢 MetaVia is trading 6.39% up with no clear catalyst identified

MetaVia is trading at $1.50, up 6.39%, on October 12, 2026; the reason for the gain remains unclear. - MetaVia’s investor-relations page lists the DA-1726 preclinical findings, dated September 9, as its latest release and shows no October 12 announcement. - Supplied market context shows no broad-index move above 0.5% in the same direction, so it does not establish a market-driven explanation.